Chicago, IL, United States of America

Chin-Tu Chen

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 239(Granted Patents)


Location History:

  • Lisle, IL (US) (1994 - 2013)
  • Chicago, IL (US) (2007 - 2019)

Company Filing History:


Years Active: 1994-2019

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Chin-Tu Chen

Introduction

Chin-Tu Chen is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of therapeutics and medical imaging. With a total of 9 patents to his name, he has made remarkable advancements that have the potential to impact medical diagnostics and treatment.

Latest Patents

One of his latest patents focuses on the use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging. This patent provides novel compounds that bind to potassium channels, along with methods for their manufacture and use. These compounds are designed to diagnose and assess traumatic brain injury, treat demyelinating diseases, and facilitate in vivo imaging of the central nervous system. Additionally, they can be used to diagnose and assess the progression of multiple sclerosis and other related diseases.

Career Highlights

Chin-Tu Chen has worked with esteemed institutions such as the University of Chicago and Arch Development Corporation. His work in these organizations has allowed him to collaborate with other experts in the field and further his research in innovative medical solutions.

Collaborations

Some of his notable coworkers include Chien-min Kao and Qingguo Xie, who have contributed to his research endeavors and patent developments.

Conclusion

Chin-Tu Chen's innovative work in the field of therapeutics and medical imaging showcases his dedication to advancing medical science. His patents reflect a commitment to improving diagnostic and treatment methods for various neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…